StemRIM (4599.T)

JPY 330.0

(-0.3%)

Revenue Summary of StemRIM

  • StemRIM's latest annual revenue in 2024 was - JPY , down -100.0% from previous year.
  • StemRIM's latest quarterly revenue in 2024 Q4 was - JPY , down 0.0% from previous quarter.
  • StemRIM reported a annual revenue of 2.35 Billion JPY in annual revenue 2023, up 10128.06% from previous year.
  • StemRIM reported a annual revenue of 22.97 Million JPY in annual revenue 2022, down -98.36% from previous year.
  • StemRIM reported a quarterly revenue of - JPY for 2024 Q4, down 0.0% from previous quarter.
  • StemRIM reported a quarterly revenue of - JPY for 2024 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of StemRIM (2024 - 2017)

Historical Annual Revenue of StemRIM (2024 - 2017)

Year Revenue Revenue Growth
2024 - JPY -100.0%
2023 2.35 Billion JPY 10128.06%
2022 22.97 Million JPY -98.36%
2021 1.4 Billion JPY -33.33%
2020 2.1 Billion JPY 2000.0%
2019 100 Million JPY -50.0%
2018 200 Million JPY -33.33%
2017 300 Million JPY 0.0%

Peer Revenue Comparison of StemRIM

Name Revenue Revenue Difference
KOHJIN BIO CO LTD 4.77 Billion JPY 100.0%
PRISM BioLab Co.,LTD 112.92 Million JPY 100.0%
GNI Group Ltd. 26.01 Billion JPY 100.0%
Linical Co., Ltd. 12.3 Billion JPY 100.0%
Trans Genic Inc. 13.08 Billion JPY 100.0%
MEDINET Co., Ltd. 661.54 Million JPY 100.0%
Soiken Holdings Inc. 5.15 Billion JPY 100.0%
Cytori Cell Research Institute, Inc. 1.56 Billion JPY 100.0%
AnGes, Inc. 152.98 Million JPY 100.0%
OncoTherapy Science, Inc. 610.11 Million JPY 100.0%
Nxera Pharma Co., Ltd. 12.76 Billion JPY 100.0%
Immuno-Biological Laboratories Co., Ltd. 816.7 Million JPY 100.0%
NanoCarrier Co., Ltd. 135.5 Million JPY 100.0%
Carna Biosciences, Inc. 1.62 Billion JPY 100.0%
CanBas Co., Ltd. - JPY NaN%
D. Western Therapeutics Institute, Inc. 428.36 Million JPY 100.0%
RaQualia Pharma Inc. 1.9 Billion JPY 100.0%
Chiome Bioscience Inc. 682.46 Million JPY 100.0%
Kidswell Bio Corporation 2.43 Billion JPY 100.0%
PeptiDream Inc. 28.71 Billion JPY 100.0%
Oncolys BioPharma Inc. 63.03 Million JPY 100.0%
Ribomic Inc. - JPY NaN%
SanBio Company Limited - JPY NaN%
Healios K.K. 121 Million JPY 100.0%
BrightPath Biotherapeutics Co., Ltd. 72 Thousand JPY 100.0%
Kubota Pharmaceutical Holdings Co., Ltd. 39.88 Million JPY 100.0%
Delta-Fly Pharma, Inc. - JPY NaN%
CellSource Co., Ltd. 4.51 Billion JPY 100.0%
FunPep Company Limited 530 Thousand JPY 100.0%
Kringle Pharma, Inc. 69.25 Million JPY 100.0%
Stella Pharma Corporation 269.49 Million JPY 100.0%
TMS Co., Ltd. - JPY NaN%
Noile-Immune Biotech Inc. 316.81 Million JPY 100.0%
Cuorips Inc. 23.1 Million JPY 100.0%
K Pharma,Inc. 1 Billion JPY 100.0%
Takara Bio Inc. 43.5 Billion JPY 100.0%
ReproCELL Incorporated 2.42 Billion JPY 100.0%
PhoenixBio Co., Ltd. 1.71 Billion JPY 100.0%
StemCell Institute Inc. 2.48 Billion JPY 100.0%
Japan Tissue Engineering Co., Ltd. 2.51 Billion JPY 100.0%
CellSeed Inc. 190.13 Million JPY 100.0%